» Authors » Marta Gromicho

Marta Gromicho

Explore the profile of Marta Gromicho including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 82
Citations 763
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Oliveira Santos M, Pinto S, Silveira F, Gromicho M, Alves I, Castro J, et al.
J Clin Neuromuscul Dis . 2025 Feb; 26(3):133-139. PMID: 40009417
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder affecting primarily the motor system. However, an association with sensory neuronopathy has been scarcely described. We described 3 unrelated patients (2 males)...
2.
Oliveira Santos M, Domingues S, Simao S, Gromicho M, Alves I, de Carvalho M
Muscle Nerve . 2025 Jan; 71(3):450-456. PMID: 39801319
Introduction/aims: Literature on the role of gastrostomy and noninvasive ventilation (NIV) in primary lateral sclerosis (PLS) is limited. We aim to investigate whether PLS patients develop dysphagia requiring feeding tubes...
3.
Santos Silva C, Gromicho M, Simao S, Pronto-Laborinho A, Alves I, Pinto S, et al.
J Neurol Sci . 2024 Dec; 468():123363. PMID: 39705762
No abstract available.
4.
Guazzo A, Atzeni M, Idi E, Trescato I, Tavazzi E, Longato E, et al.
BMC Med Inform Decis Mak . 2024 Oct; 24(Suppl 4):318. PMID: 39472842
Background: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that results in death within a short time span (3-5 years). One of the major challenges in treating ALS is...
5.
Alves I, Gromicho M, Oliveira Santos M, Pinto S, de Carvalho M
Amyotroph Lateral Scler Frontotemporal Degener . 2024 Sep; 26(1-2):58-63. PMID: 39340290
Background: The rate of disease progression, measured by the decline of ALS Functional Rating Scale-Revised (ALSFRS-R) from symptom onset to diagnosis (ΔFS) is a well-established prognostic biomarker for predicting survival....
6.
Faggioli G, Menotti L, Marchesin S, Chio A, Dagliati A, de Carvalho M, et al.
J Biomed Semantics . 2024 Aug; 15(1):16. PMID: 39210467
Automatic disease progression prediction models require large amounts of training data, which are seldom available, especially when it comes to rare diseases. A possible solution is to integrate data from...
7.
Simao S, Oliveira Santos M, Gromicho M, Martins I, de Carvalho M
Amyotroph Lateral Scler Frontotemporal Degener . 2024 Aug; 25(7-8):726-736. PMID: 39101689
: Amyotrophic lateral sclerosis (ALS) has heterogeneous manifestations ranging from motor neuron degeneration to cognitive and behavioral impairment. This study aims to clarify the interactions between cognition and behavioral symptoms...
8.
Correia J, Gromicho M, Pronto-Laborinho A, Oliveira Santos M, de Carvalho M
Brain Sci . 2024 Jul; 14(7). PMID: 39061402
Respiratory dysfunction is an important hallmark of amyotrophic lateral sclerosis (ALS). Elevation of creatine kinase (CK) has been reported in 23-75% of ALS patients, but the underlying mechanisms remain unknown....
9.
M Amaral D, Soares D, Gromicho M, de Carvalho M, Madeira S, Tomas P, et al.
Nat Commun . 2024 Jul; 15(1):5717. PMID: 38977678
Identifying groups of patients with similar disease progression patterns is key to understand disease heterogeneity, guide clinical decisions and improve patient care. In this paper, we propose a data-driven temporal...
10.
Santos Silva C, Correia Rodrigues C, Baptista M, Oliveira Santos M, Gromicho M, Carvalho V, et al.
Muscle Nerve . 2024 Apr; 70(1):152-156. PMID: 38687249
Introduction/aims: The frequency and distribution of upper motor neuron (UMN) signs in primary lateral sclerosis (PLS) are unknown. We aimed to study the spectrum of UMN signs in PLS and...